649 Phase 1a open-label, non-randomized, multi-center clinical trial of intratumoral IVX037 in patients with advanced microsatellite stable (MSS) colorectal, gastroesophageal or ovarian cancer
| Published in: | Journal for ImmunoTherapy of Cancer |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2023-11-01
|
| _version_ | 1850265855182503936 |
|---|---|
| author | Jia Liu Timothy Price Mark Wong Rafid Al-Asady Eugene Hsu Niall Tebbutt Darren R Shafren Naomi Croll |
| author_facet | Jia Liu Timothy Price Mark Wong Rafid Al-Asady Eugene Hsu Niall Tebbutt Darren R Shafren Naomi Croll |
| author_sort | Jia Liu |
| collection | DOAJ |
| container_title | Journal for ImmunoTherapy of Cancer |
| format | Article |
| id | doaj-art-892a68eecbaa4f549180dea36daeefeb |
| institution | Directory of Open Access Journals |
| issn | 2051-1426 |
| language | English |
| publishDate | 2023-11-01 |
| publisher | BMJ Publishing Group |
| record_format | Article |
| spelling | doaj-art-892a68eecbaa4f549180dea36daeefeb2025-08-19T23:44:51ZengBMJ Publishing GroupJournal for ImmunoTherapy of Cancer2051-14262023-11-0111Suppl 110.1136/jitc-2023-SITC2023.0649649 Phase 1a open-label, non-randomized, multi-center clinical trial of intratumoral IVX037 in patients with advanced microsatellite stable (MSS) colorectal, gastroesophageal or ovarian cancerJia Liu0Timothy Price1Mark Wong2Rafid Al-Asady3Eugene Hsu4Niall Tebbutt5Darren R Shafren6Naomi Croll72 Research Institute of Pancreatic Diseases, Shanghai Key Laboratory of Translational Research for Pancreatic Neoplasms, Shanghai Jiaotong University School of Medicine, Shanghai, People`s Republic of ChinaMedical Oncology, The Queen Elizabeth Hospital and The University of Adelaide, Adelaide, South Australia, AustraliaUrban Studies, School of Social and Political Sciences, University of Glasgow, Glasgow, UKDepartment of Radiology, Westmead Hospital, Westmead, New South Wales, AustraliaGovernment Business Division, Elevance Health, Indianapolis, Indiana, USA3Austin Hospital, Melbourne, VIC, Australia5Immvirx, Newcastle, NSW, Australia5Immvirx, Newcastle, NSW, Australia |
| spellingShingle | Jia Liu Timothy Price Mark Wong Rafid Al-Asady Eugene Hsu Niall Tebbutt Darren R Shafren Naomi Croll 649 Phase 1a open-label, non-randomized, multi-center clinical trial of intratumoral IVX037 in patients with advanced microsatellite stable (MSS) colorectal, gastroesophageal or ovarian cancer |
| title | 649 Phase 1a open-label, non-randomized, multi-center clinical trial of intratumoral IVX037 in patients with advanced microsatellite stable (MSS) colorectal, gastroesophageal or ovarian cancer |
| title_full | 649 Phase 1a open-label, non-randomized, multi-center clinical trial of intratumoral IVX037 in patients with advanced microsatellite stable (MSS) colorectal, gastroesophageal or ovarian cancer |
| title_fullStr | 649 Phase 1a open-label, non-randomized, multi-center clinical trial of intratumoral IVX037 in patients with advanced microsatellite stable (MSS) colorectal, gastroesophageal or ovarian cancer |
| title_full_unstemmed | 649 Phase 1a open-label, non-randomized, multi-center clinical trial of intratumoral IVX037 in patients with advanced microsatellite stable (MSS) colorectal, gastroesophageal or ovarian cancer |
| title_short | 649 Phase 1a open-label, non-randomized, multi-center clinical trial of intratumoral IVX037 in patients with advanced microsatellite stable (MSS) colorectal, gastroesophageal or ovarian cancer |
| title_sort | 649 phase 1a open label non randomized multi center clinical trial of intratumoral ivx037 in patients with advanced microsatellite stable mss colorectal gastroesophageal or ovarian cancer |
| work_keys_str_mv | AT jialiu 649phase1aopenlabelnonrandomizedmulticenterclinicaltrialofintratumoralivx037inpatientswithadvancedmicrosatellitestablemsscolorectalgastroesophagealorovariancancer AT timothyprice 649phase1aopenlabelnonrandomizedmulticenterclinicaltrialofintratumoralivx037inpatientswithadvancedmicrosatellitestablemsscolorectalgastroesophagealorovariancancer AT markwong 649phase1aopenlabelnonrandomizedmulticenterclinicaltrialofintratumoralivx037inpatientswithadvancedmicrosatellitestablemsscolorectalgastroesophagealorovariancancer AT rafidalasady 649phase1aopenlabelnonrandomizedmulticenterclinicaltrialofintratumoralivx037inpatientswithadvancedmicrosatellitestablemsscolorectalgastroesophagealorovariancancer AT eugenehsu 649phase1aopenlabelnonrandomizedmulticenterclinicaltrialofintratumoralivx037inpatientswithadvancedmicrosatellitestablemsscolorectalgastroesophagealorovariancancer AT nialltebbutt 649phase1aopenlabelnonrandomizedmulticenterclinicaltrialofintratumoralivx037inpatientswithadvancedmicrosatellitestablemsscolorectalgastroesophagealorovariancancer AT darrenrshafren 649phase1aopenlabelnonrandomizedmulticenterclinicaltrialofintratumoralivx037inpatientswithadvancedmicrosatellitestablemsscolorectalgastroesophagealorovariancancer AT naomicroll 649phase1aopenlabelnonrandomizedmulticenterclinicaltrialofintratumoralivx037inpatientswithadvancedmicrosatellitestablemsscolorectalgastroesophagealorovariancancer |